A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia
Clinical trial NCT00210769 · COMPLETED
Trial details
- NCT number
- NCT00210769
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.